SyntheticMR Receives Regulatory Approval for their Innovative SyMRI Software Solution in South Korea
SyntheticMR announced today that their quantitative imaging software solution SyMRI 12.1 has received regulatory approval in South Korea according to KFDA (Korea Food & Drug Administration). This means that SyMRI 12.1 now can be sold and distributed in this market.“This approval for SyMRI 12.1 creates vital opportunities for us to develop our market presence in South Korea, which is one of our focus markets. We already have an established customer base in the region” says Ulrik Harrysson, CEO at SyntheticMR. “We have also seen a growing interest for our products in the region, which is very